Search results
Regulatory Compliance System is an online system of PDEA Compliance Service designed for application of PDEA licenses or permits, semi-annual reports, and other transactions.
30 lip 2024 · This page provides answers to some of the most frequently asked questions about psychedelic substances. The main focus is on the therapeutic use of psychedelics, but the FAQs also provide information about prevalence and patterns of use, the presence of unlicensed and illegal psychedelic practices, and developments in clinical research.
Content. Unmet medical need for treatment of mental disorders and increasing interest in psychedelic research. Regulatory (clinical) background - High level. Main scientific and regulatory challenges for psychedelics. What can be offered – European regulatory framework? Conclusions with a view to the future. Questions.
16 kwi 2024 · This multi-stakeholder workshop brings together patients, healthcare professionals, academia, regulators, and industry to discuss the development and therapeutic use of psychedelic substances to address unmet medical needs in the area of mental health.
Psychedelic drugs, acting on the central nervous system, necessitate scrutiny for abuse potential. In the case of Schedule I controlled substances, compliance with DEA regulations is mandatory for activities under an IND.
This overview seeks to map out drug discovery & development activity in psychedelics. Drugs currently undergoing clinical trials are presented first, while drugs that are at the discovery or preclinical stage are catalogued in the latter half of this page.
30 sie 2024 · A discussion of the federal legal and regulatory framework that controls the research, approval, and marketing of psychedelic drug products, including the role of the Food and Drug...
